featured
Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation: A Randomized, Double-Blind, Crossover Study in People With Type 1 Diabetes
Diabetes Care 2023 Jan 30;[EPub Ahead of Print], E Svehlikova, NL Ashcroft, C Gatschelhofer, D Gerring, V Höller, J Jezek, B Lackner, F Lawrence, V Pillai, M Ratzer, M Urschitz, M Wolf, TR PieberFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.